10-Q: AXT Q2 2025: Revenue Plunges Amid China Export Curbs

AXT, Inc. reported a significant revenue decline and increased net loss for Q2 2025, primarily driven by China's export restrictions on semiconductor substrates and unfavorable production yields.

Summary

• Total revenue for the three months ended June 30, 2025, decreased by 35.6% to $17.97 million from $27.92 million in the same period of 2024.
• Substrate revenue declined by 42.8% to $11.29 million, while raw materials and other revenue decreased by 18.3% to $6.68 million for the quarter.
• Gross profit plummeted by 81.3% to $1.43 million for the quarter, with the gross margin falling to 8.0% from 27.4% year-over-year.
• Net loss attributable to AXT, Inc. widened to $7.01 million, or $0.16 per basic and diluted share, for the three months ended June 30, 2025, compared to a net loss of $1.52 million, or $0.04 per share, in the prior year period.
• For the six months ended June 30, 2025, total revenue decreased by 26.2% to $37.33 million, and gross profit fell by 98.6% to $0.19 million, resulting in a gross margin of 0.5%.
• Net loss attributable to AXT, Inc. for the six-month period was $15.81 million, or $0.36 per basic and diluted share, compared to $3.60 million, or $0.09 per share, in the same period of 2024.
• The decline in substrate revenue was primarily due to lower demand for Indium Phosphide (InP) wafer substrates used in data center applications and passive optical networks, impacted by China's export restrictions, and decreased demand for Gallium Arsenide (GaAs) and Germanium (Ge) wafer substrates.
• Gross profit was significantly impacted by unfavorable yields in gallium arsenide production lines and increased unabsorbed overhead due to lower substrate revenue.
• Cash and cash equivalents increased to $27.01 million as of June 30, 2025, from $22.83 million at December 31, 2024, while restricted cash decreased to $8.10 million from $10.98 million.
• Total current assets decreased to $144.96 million from $158.27 million, and total assets decreased to $329.00 million from $339.31 million.
• Short-term loans increased to $55.93 million from $47.26 million, and total liabilities increased to $88.37 million from $84.41 million.
• An impairment charge of $145,000 was recognized for the Jia Mei investment during the six months ended June 30, 2025, due to a decline in fair value.

Sentiment

Score: 2

Explanation: The sentiment is strongly negative due to significant declines in revenue and gross profit, substantial net losses, and ongoing operational challenges stemming from geopolitical trade tensions and export restrictions. While some cost reductions were achieved and cash flow from financing was positive, the core business performance is severely impacted, and key uncertainties like U.S. export permits and the Tongmei IPO timeline persist. The Nasdaq compliance issue and ongoing legal proceedings add further negative pressure.

Positives

• Net cash provided by financing activities increased to $6.56 million for the six months ended June 30, 2025, compared to $3.68 million in the prior year period.
• Net cash used in investing activities decreased to $1.63 million for the six months ended June 30, 2025, from $4.46 million in the prior year period.
• Raw materials sales for the six months ended June 30, 2025, increased by 7.0% to $14.96 million, primarily due to increased sales of refined gallium and recycled materials.
• Initial export permits for Indium Phosphide (InP) substrates to Europe, Japan, UK, and Canada were received from China's Ministry of Commerce, allowing resumption of shipments to these regions.
• Selling, general and administrative expenses decreased by 2.2% for the three months and 3.6% for the six months ended June 30, 2025, primarily due to lower legal and professional service expenses, outside commissions, and office supply expenses.
• Research and development expenses decreased by 32.8% for the three months and 19.1% for the six months ended June 30, 2025, mainly due to lower product development expenses for crystal ingot processing.
• Interest expense, net, decreased by 28.4% for the three months and 25.4% for the six months ended June 30, 2025, due to higher interest income.

Negatives

• Total revenue decreased significantly by 35.6% for the three months and 26.2% for the six months ended June 30, 2025, primarily due to lower demand and export restrictions.
• Gross profit declined sharply by 81.3% for the three months and 98.6% for the six months ended June 30, 2025, largely due to significant unfavorable yields in gallium arsenide production and increased unabsorbed overhead.
• Net loss attributable to AXT, Inc. increased substantially to $7.01 million for the quarter and $15.81 million for the six-month period.
• China's export restrictions on Indium Phosphide (InP) substrates, effective February 4, 2025, have negatively impacted product mix and total substrate revenue, with uncertainty remaining for U.S. shipments.
• U.S. tariffs on products from China, including wafer substrates, increased to 100% in the first half of April 2025, increasing costs and potentially impacting sales.
• No permits for gallium arsenide exports to the U.S. have been approved due to U.S. customers being considered dual-use customers (commercial and military applications).
• Inventory reserves for excess and obsolete inventory increased to $26.5 million as of June 30, 2025, from $24.1 million at December 31, 2024.
• The company is currently non-compliant with Nasdaq Listing Rule 5605(c)(2)(A) regarding the Audit Committee's independent director requirement due to a director's passing.
• A $145,000 impairment charge was recorded for the Jia Mei investment due to fair value decline.
• Government grants, a component of other income, net, decreased significantly by 95.3% for the three months and 75.2% for the six months ended June 30, 2025.

Risks

• Global economic and political conditions, including trade tariffs, import-export restrictions, and other trade barriers, may negatively impact business and financial results.
• The PRC central government may intervene in or influence PRC operations at any time, and rules and regulations in China can change quickly with little advance notice, potentially affecting operations or stock value.
• There is no guarantee that future audit reports will be prepared by an independent registered public accounting firm that is completely inspected by the PCAOB, potentially limiting access to U.S. capital markets.
• The NASDAQ stock price is volatile and could decline due to unpredictable fluctuations in operating results, changes in end markets, and global trends.
• Ongoing litigation and legal proceedings, including a shareholder class action and a derivative lawsuit, could adversely affect business, financial condition, results of operations, or cash flows.
• Changes in China's political, social, regulatory, or economic environments may affect financial performance, including environmental controls and tax policies.
• Mandatory factory shutdowns due to air pollution or other environmental concerns in China could impact manufacturing output, revenue, and factory utilization.
• The proposed Tongmei IPO on the STAR Market in China could fail, leading to investor disappointment and failure to secure sufficient capital, potentially causing stock price decline.
• The terms of private equity raised by Tongmei grant investors a right of redemption (approximately $49 million) if the IPO fails, which could require AXT to seek additional capital.
• Defects in products could diminish demand, lead to product rejections, compensation costs, and loss of market share.
• Difficulties in accurately estimating market demand could result in over-investing in inventory, equipment, and capacity expansion, or losing market share if investments are insufficient.
• Attracting and retaining tier one customers requires successful research and development programs to meet stringent product specifications, which may not always be achieved.
• Exposure to foreign exchange gains and losses can materially impact consolidated statements of operations, especially during periods of currency volatility.
• Joint venture raw material companies in China bring specific risks, including operational disruptions if partners experience problems or deliberately disrupt services, and potential liability for environmental violations.
• Unforeseen manufacturing issues and restrictions at new manufacturing sites could occur, disrupting production and impacting revenue.
• Demand for products may decrease if demand for end-user applications declines or if downstream manufacturers face difficulties.
• Unfavorable financial results in raw material companies could negatively impact consolidated revenue, gross margin, and profitability.
• Intense competition in product markets could prevent revenue increases and profitability, with competitors having significant advantages.
• Average selling prices of substrates may decline over short periods, reducing revenue and gross margins.
• Loss of one or more tier one substrate customers would significantly hurt operating results.
• Strategic investments in raw materials suppliers may not be successful and could result in loss of investment.
• Damage to facilities from fire, explosion, power outage, or natural disaster could prevent product manufacturing.
• Long qualification cycles for substrate products make it difficult to forecast revenue from new customers or products.
• The cyclical nature of the semiconductor industry may limit ability to maintain or increase net sales and operating results during downturns.
• Cyber-attacks, system security risks, and data protection issues could disrupt internal operations, reduce revenue, and increase expenses.
• Health epidemics and other outbreaks could significantly disrupt business operations, including mandatory factory closures.
• Financial market volatility and adverse changes in the domestic, global, political, and economic environment could have a significant adverse impact.
• The PRC central government may exert more control over overseas offerings and foreign investment in China-based issuers, potentially limiting access to capital markets.
• International operations are exposed to potential adverse tax consequences in China, including transfer pricing challenges and VAT assessments.
• Dividends from within the corporate structure are subject to PRC withholding tax and State Administration of Foreign Exchange (SAFE) approval.
• PRC subsidiaries and joint ventures are subject to data security oversight by the Cyberspace Administration of China (CAC).
• Restrictions on freight and transportation routes and ports of entry/departure in China could result in shipping delays or increased costs.
• Power shortages in China could lead to temporary closures of operations, impacting manufacturing and revenue.
• Ability to use net operating loss carryforwards and certain other tax attributes may be limited due to ownership changes.

Future Outlook

The company expects the Tongmei IPO on the STAR Market to be accomplished in the coming months, subject to review and approval by the CSRC and other authorities. The timing for receiving necessary export permits to resume shipping indium phosphide substrates to the U.S. remains uncertain. The company anticipates similar cycles of strong demand followed by lower demand for various InP, GaAs, or Ge substrates in the future. Management believes it has adequate cash and investments to meet operating needs and capital expenditures over the next 12 months, but acknowledges that decreased sales could adversely affect future liquidity and require additional capital.

Management Comments

• The decrease in gross profit is primarily the result of significant unfavorable yields charged to cost of goods sold in our gallium arsenide production lines.
• The export restrictions imposed by China on indium phosphide had a negative impact on product mix and on total substrate revenue.
• Sales of indium phosphide wafers were reduced significantly.
• Lower substrate revenue resulted in an increase in unabsorbed overhead charged to cost of goods sold.
• We have little or no germanium imports into the U.S. and historically a relatively small value of imports of gallium arsenide wafers into the U.S.
• Our primary revenue generator derived from imports into the U.S. is indium phosphide substrates.
• While Tongmei has generally received the required permits for exports to countries in Asia and Europe, our U.S. gallium arsenide customers are considered dual use customers: in addition to commercial applications they have significant levels of military involvement. As such, no permits for gallium arsenide to the U.S. have yet been approved.
• To our knowledge, indium phosphide is rarely used in military applications and we can reasonably expect that export permits to ship our indium phosphide substrates to the U.S. will be granted. However, since the requirement for such export permits is new, the timing for when permits will be granted remains uncertain and we are unable to estimate when we will receive the necessary export permits to resume shipping our indium phosphide substrates to the U.S. We are actively monitoring and following up on the status of our applications.
• We believe these claims [legal proceedings] to be meritless and intend to vigorously defend against them.
• We believe that we have adequate cash and investments to meet our operating needs and capital expenditures over the next 12 months.

Industry Context

The semiconductor industry is highly cyclical, characterized by periods of diminished product demand, overcapacity, and rapid erosion of average selling prices. The current period reflects an inventory correction cycle that began in the second half of 2022, following over-purchasing due to COVID-related supply chain fears. Demand for high-speed data transfer, driven by AI applications, is expected to increase InP substrate demand. The industry also sees ongoing shifts in material adoption, with silicon-based technologies like SOI posing a competitive threat to specialty materials like GaAs due to cost advantages. Geopolitical tensions, particularly between China and the U.S., are significantly impacting the industry through escalating tariffs and export controls, encouraging domestic production and creating an unstable business environment.

Comparison to Industry Standards

• The filing does not provide specific comparable companies or global benchmarks for direct performance comparison.
• The company operates in a highly competitive market, facing competition from other substrate manufacturers such as Sumitomo, JX, Freiberger, Umicore, Vital, and CCTC.
• Competitors like Qorvo and Skyworks are exploring alternative materials to GaAs, indicating a dynamic competitive landscape.
• The company's gross margin of 8.0% for Q2 2025 and 0.5% for H1 2025 is significantly lower than its historical performance (e.g., 27.4% in Q2 2024, 42.0% in Q3 2022), suggesting a performance well below industry averages for specialty material manufacturers, which typically command higher margins due to specialized products.
• The impact of export restrictions and tariffs, particularly the 100% U.S. tariff on products from China, places the company at a significant disadvantage compared to competitors not facing similar trade barriers or those with diversified manufacturing bases outside China.
• The reliance on China for all wafer substrate manufacturing and most raw material sourcing exposes the company to unique geopolitical and regulatory risks not equally shared by all global competitors.

Management Changes

Corporate Governance

Legal Proceedings

• A putative shareholder class action complaint was filed on May 6, 2024, in the U.S. District Court for the Eastern District of New York (later transferred to Northern District of California) against the company, CEO Morris S. Young, and CFO Gary L. Fischer, alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5. The court granted a motion to dismiss with leave to amend on May 28, 2025, and a second amended complaint was filed on June 27, 2025. Defendants again moved to dismiss on July 11, 2025, with the motion pending.
• A derivative lawsuit was filed on August 22, 2024, in the Northern District of California by an alleged shareholder against Morris S. Young, Gary L. Fischer, and current/former directors, with the company as a nominal defendant, alleging breach of fiduciary duties. The court granted the motion to dismiss on March 17, 2025, for failure to make a pre-suit demand and failure to state a claim. The plaintiff filed a notice of appeal on May 13, 2025.

Related Party Transactions

• In September and October 2021, ChaoYang XinMei, a consolidated subsidiary, received $0.9 million and $1.0 million, respectively, in funding from a minority investor, initially recorded as a short-term loan from noncontrolling interest.
• In December 2021 and January 2022, ChaoYang XinMei received $1.4 million and $1.4 million, respectively, in funding from Tongmei, which was certified as an equity investment by the China local government.
• In April and May 2022, ChaoYang XinMei received additional equity funding from Tongmei ($1.1 million and $0.8 million) and minority investors ($0.7 million and $0.6 million) under a Capital Increase Agreement.
• In July 2022, Tongmei and minority investors further invested $0.8 million and $0.6 million, respectively, in ChaoYang XinMei, completing the Capital Increase Agreement obligations.
• In September 2022, ChaoYang LiMei, a consolidated subsidiary, sold land and buildings to ChaoYang KaiMei, an equity investment entity, for $1.5 million, which was paid in January 2023.

Stakeholder Impact

• Shareholders: Significant decline in revenue, gross profit, and increased net loss are likely to negatively impact share price and investor confidence. The ongoing Nasdaq compliance issue and legal proceedings add further uncertainty and risk to shareholder value.
• Employees: Unfavorable production yields and lower revenue could lead to potential restructuring or workforce adjustments, impacting job security and morale.
• Customers: Export restrictions from China and increased U.S. tariffs could lead to supply delays, higher costs, and limited product availability, potentially forcing customers to seek alternative suppliers and impacting customer relationships.
• Suppliers: Reduced demand for the company's products could lead to lower orders for raw materials and components, impacting suppliers' business volumes.
• Creditors: Increased short-term loans and overall liabilities, coupled with significant losses, could raise concerns about the company's financial health and ability to service debt, although management believes it has adequate liquidity for the next 12 months.

Next Steps

• Regain compliance with Nasdaq Listing Rule 5605(c)(2)(A) regarding the Audit Committee's independent director requirement by the cure period deadline (earlier of next annual meeting or July 11, 2026, or January 7, 2026 if annual meeting before then).
• Continue actively monitoring and following up on the status of applications for export permits for indium phosphide substrates to the U.S.
• Tongmei to continue the process for its Initial Public Offering (IPO) on the Shanghai Stock Exchange's Sci-Tech innovAtion boaRd (STAR Market), subject to review and approval by the CSRC and other authorities, with the goal of accomplishing this in the coming months.
• Monitor macroeconomic conditions and evaluate the financial and operational impact of ongoing trade policy shifts, including tariffs and export regulations.
• Continue efforts to improve yields and manufacturing efficiencies and reduce product costs to combat declining average selling prices.
• Manage inventory levels effectively to meet changing customer requirements and avoid excess or obsolete inventory charges.

Key Dates

Recommendation

The company's financial performance is severely deteriorating, marked by a substantial decline in revenue and a near collapse in gross profit, leading to significantly increased net losses. This is primarily driven by external factors such as escalating U.S.-China trade tensions, including 100% tariffs and export restrictions on key products like Indium Phosphide and Gallium Arsenide, which directly impact sales and profitability. Operational issues like unfavorable production yields further exacerbate the situation. The ongoing legal proceedings and Nasdaq compliance issues add layers of uncertainty and risk. While the company has secured some financing, the fundamental business outlook is highly challenged by geopolitical factors beyond its control, making future recovery highly uncertain. The combination of poor financial results, significant external headwinds, and unresolved legal/governance issues presents a high-risk investment profile with substantial downside potential.

Keywords

Semiconductor, Wafers, Indium Phosphide, Gallium Arsenide, Germanium, Raw Materials, China Export Controls, Trade Tariffs, SEC Filing, Quarterly Report, Substrates, Compound Semiconductor, Optoelectronics, Supply Chain, STAR Market IPO, Financial Results, Manufacturing Yields, Geopolitical Risk